Mental Disorders

At Boehringer Ingelheim Mental Health, we are redefining mental health to enable people to thrive. We link behavior to the underlying neurobiology to develop targeted therapies that can ease the burden of these conditions, not just the symptoms. By combining traditional treatment approaches with new and innovative approaches and technologies, we will enable those with mental health conditions such as Schizophrenia, Borderline Personality Disorder or Depression to create more meaningful connections to their lives, loved ones and society.

Boehringer Ingelheim has a rich pipeline in all phases of development.

Latest Articles on Mental Disorders

Illustration of woman and man on a puzzle

Mental Disorders

Mental Health and the Value of Connection

Yammie and Jurgen share their story of friendship, and how much they value connection as people living with mental health conditions.

Dr. Hugh Marston and Dr. Vikas Mohan Sharma discuss how precision psychiatry can enable people living with mental health conditions to thrive.

Mental Disorders

Bringing Precision to Psychiatry

Dr. Hugh Marston and Dr. Vikas Mohan Sharma discuss what precision psychiatry entails and how it can enable people living with mental health conditions to thrive.

Schizophrenia is characterized by three symptom domains and affects ~1% of global population. First and mostly known are the positive symptoms like hallucinations and delusions, secondly are negative symptoms like reduced emotion and lack of motivation and the third symptom domain is cognitive symptoms like a poor memory or disorganized thinking. While there are already many drugs for treating positive symptoms, there is a significant unmet medical need for effective treatments for negative and cognitive symptoms.